Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Sep 1.

Published in final edited form as: Gynecol Oncol. 2015 Jul 3;138(3):614–619. doi: 10.1016/j.ygyno.2015.06.038

Table 4.

Multivariate analyses

Characteristic	Overall Survival			Disease-free Survival
Characteristic	HR	95% CI	P	HR	95% CI	P
Age	1.028	1.006 – 1.051	0.013	1.034	1.012 – 1.057	0.003
ATR mutation	0.921	0.422 – 2.010	0.836	0.513	0.187 – 1.407	0.195
High tumor grade	2.007	1.212 – 3.324	0.007	1.517	0.900 – 2.557	0.118
Advanced surgical stage	1.598	0.887 – 2.881	0.119	1.633	0.908 – 2.937	0.102
Adjuvant treatment	0.613	0.339 – 1.111	0.107	0.818	0.463 – 1.445	0.489
Deep myometrial invasion	2.667	1.539 – 4.622	<0.001	1.778	1.023 – 3.091	0.041
LVSI	1.390	0.810 – 2.385	0.232	1.326	0.769–2.288	0.310